Treatment switching guided by liquid biopsy results improves outcomes in advanced bre

[News]

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care.

More... (https://www.news-medical.net/news/20250601/Treatment-switching-guided-by-liquid-biopsy-results-improves-outcomes-in-advanced-breast-cancer.aspx)